Ironwood Pharmaceuticals (IRWD) Short-term Investments (2010 - 2023)

Ironwood Pharmaceuticals has disclosed Short-term Investments across 14 years of filings, most recently posting $788000.0 for Q3 2023.

• In Q3 2023, Short-term Investments fell 36.96% year-over-year to $788000.0; the TTM figure through Sep 2023 stood at $788000.0 (down 36.96% YoY), while the FY2022 annual figure was $1.3 million, changed 0.0% from the prior year.
• Short-term Investments came in at $788000.0 for Q3 2023 at Ironwood Pharmaceuticals, roughly flat from $788000.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $11.3 million in Q2 2021 to a low of $788000.0 in Q2 2023.
• Average Short-term Investments over 5 years is $2.8 million, with a median of $1.3 million recorded in 2021.
• Year-over-year, Short-term Investments sank 97.48% in 2019 and jumped 800.96% in 2021.
• Over 5 years, Short-term Investments stood at $1.2 million in 2019, then jumped by 38.8% to $1.7 million in 2020, then decreased by 25.07% to $1.3 million in 2021, then changed by 0.0% to $1.3 million in 2022, then slumped by 39.38% to $788000.0 in 2023.
• Per Business Quant data, the three most recent Short-term Investments figures were $788000.0 in Q3 2023, $788000.0 in Q2 2023, and $1.2 million in Q1 2023.